R&D News | pharmaphorum

News

US government appeals after judge blocks NIH funding cap

HHS has said it plans to appeal a permanent injunction on big cuts to indirect funding for medical research awarded by the NIH.

News

CRUK scientists find new tool to test lung cancer therapies

Researchers in the UK have developed a lung cancer cell line that they believe could be an important new tool for the discovery of new therapies.

News

Report says US biotech needs $15bn support to fend off China

The US is close to falling behind China in biotech and the government should spend a minimum of $15bn over the next five years to support the sector.

News

Pharma warns EU of "exodus to US" without reform

Pharma leaders have told the EU that without reforms the bloc could lose out on major capital investment programmes and R&D spending.

News

UK unveils £600m investment in health data research

The UK government and Wellcome Trust will invest £600m in a Health Data Research Service to unlock the power of NHS patient data for medical research.

News

GSK makes fresh neuroscience foray with £2bn+ ABL deal

Neuroscience isn't listed as one of the top R&D priorities at GSK, but a new alliance with ABL Bio adds to the sense that its focus may be shifting.

US government appeals after judge blocks NIH funding cap

CRUK scientists find new tool to test lung cancer therapies

Report says US biotech needs $15bn support to fend off China

Pharma warns EU of "exodus to US" without reform

UK unveils £600m investment in health data research

GSK makes fresh neuroscience foray with £2bn+ ABL deal

Merck rare tumour drug Ezmekly backed for NHS use

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks